Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry is a **pseudogene** that shares sequence similarity with the true eukaryotic translation initiation factor 2A (EIF2A), a protein involved in the initiation of mRNA translation in eukaryotic cells, but **does not produce a functional protein itself**. As a pseudogene, it is a non-functional genomic DNA sequence resembling a gene, often regarded as a "genomic fossil," and is not considered a therapeutic target, receptor, enzyme, transporter, or a protein of molecular function. **Key context and details:** - **Pseudogenes** are not translated into functional proteins and typically do not have biological or disease-related roles, nor do they interact with drugs or act as biomarkers. - The canonical EIF2A gene (not this pseudogene) would be classified as a translation initiation factor and has established protein function, but ENSG00000270990/EIF2AP3 is not the equivalent protein-coding gene. - If your intention was to retrieve information about the genuine translation initiation factor 2A, a new search for **EIF2A (not pseudogene)** is needed. This entry is not a valid or actionable therapeutic target due to its pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2A, 65kDa, pseudogene (EIF2AP3).